oxid
stress
consid
major
risk
factor
contribut
increas
lipid
peroxid
declin
antioxid
degen
diseas
glycyrrhizin
wide
use
cure
allerg
diseas
due
medicin
properti
present
studi
evalu
role
glycyrrhizin
lipid
peroxid
antioxid
statu
blood
nasal
mucosa
allerg
rhiniti
ar
mice
mice
divid
six
group
normal
control
mice
model
control
mc
mice
three
glycyrrhizintr
mice
group
lycopenetr
mice
sensitizationassoci
increas
lipid
peroxid
observ
blood
nasal
mucosa
mc
mice
activ
antioxid
enzym
like
superoxid
dismutas
sod
catalas
cat
glutathion
peroxidas
gshpx
total
antioxid
capac
taoc
level
glutathion
gsh
found
significantli
decreas
blood
nasal
mucosa
mc
mice
compar
normal
control
mice
howev
normal
lipid
peroxid
antioxid
defens
report
glycyrrhizintr
lycopenetr
mice
moreov
glycyrrhizin
treatment
still
enhanc
reduc
level
glycyrrhizintr
mice
find
demonstr
glycyrrhizin
treatment
enhanc
antioxid
statu
int
j
mol
sci
decreas
incid
free
radicalinduc
lipid
peroxid
improv
immun
activ
blood
nasal
mucosa
ar
mice
allerg
rhiniti
ar
affect
adolesc
younger
children
ar
may
regard
parent
irrit
rather
signific
diseas
often
underdiagnos
undertr
recogn
ar
made
classic
symptom
sneez
rhinorrhea
nasal
obstruct
ar
associ
impair
patient
function
daytoday
life
home
work
school
patient
may
also
bother
sleep
disord
emot
problem
impair
activ
social
function
allerg
ar
one
frequent
diseas
encount
clinic
practic
cost
implic
societi
enorm
suggest
oxid
stress
crucial
event
perenni
ar
oxid
stress
incrimin
one
sever
mechan
induc
toxic
effect
differ
organ
due
enhanc
product
oxygen
free
radic
glycyrrhizin
triterpen
glycosid
major
activ
constitu
licoric
root
glycyrrhiza
glabra
attribut
numer
pharmacolog
effect
like
antiinflammatori
antivir
antitumor
antioxid
hepatoprotect
activ
recent
glycyrrhizin
report
mani
immunomodulatori
effect
decreas
recurr
attack
rate
ar
asthma
improv
semen
qualiti
treatment
modul
allerg
inflamm
murin
model
asthma
japan
glycyrrhizin
inject
use
therapeut
drug
allergi
inflamm
sinc
chronic
hepat
sinc
ram
et
al
demonstr
glycyrrhizin
significantli
reduc
ovainduc
airway
constrict
airway
hyperreact
methacholin
decreas
lung
inflamm
includ
mark
eosinophil
infiltr
mous
model
asthma
addit
reduc
ova
specif
ige
level
serum
cytokin
bal
fluid
glycyrrhizin
proven
import
potenti
activ
certain
immun
function
induct
ifn
product
augment
nk
cell
activ
modul
growth
respons
lymphocyt
augment
product
dai
et
al
investig
effect
glycyrrhizin
product
cytokin
found
enhanc
messeng
rna
accumul
protein
secret
periton
macrophag
respons
lipopolysaccharid
object
studi
determin
antioxid
immunomodulatori
effect
glycyrrhizin
ar
mice
would
benefici
ar
drug
therapi
dri
root
licoric
g
coars
ground
extract
boil
water
l
accord
nokhodchi
mothod
combin
solut
filter
steril
filter
boil
min
set
asid
room
temperatur
h
solut
filter
elimin
albuminoid
substanc
time
solut
acidifi
gradual
sulfur
acid
vv
stepbystep
precipit
occur
yellow
precipit
g
separ
centrifug
redissolv
small
amount
ammonium
hydroxid
volum
adjust
ml
distil
water
precipit
procedur
sulfur
acid
repeat
precipit
materi
rins
sever
time
water
order
neutral
sulfur
acid
pasti
acid
insolubl
precipit
dri
ground
fine
powder
obtain
sampl
analyz
hplc
puriti
result
glycyrrhizin
male
kunm
mice
g
bodi
weight
bw
monthold
kept
polyacryl
cage
cm
cm
cm
ten
anim
per
cage
hous
room
control
temperatur
rel
humid
h
lightdark
cycl
mice
ad
libitum
access
food
form
dri
pellet
water
mice
sensit
subcutan
inject
sc
mg
antigen
ovalbumin
mix
mg
aluminum
hydroxid
adjuv
ml
salin
footpad
neck
back
groin
first
day
local
challeng
perform
everyday
day
day
drip
ovalbumin
physiolog
salin
mg
ml
bilater
nasal
caviti
use
micropipett
mice
normal
control
drip
salin
procedur
accord
china
nation
anim
care
guidelin
mice
randomli
divid
six
group
normal
control
model
lycopen
mg
kg
posit
control
drug
group
glycyrrhizin
mg
kg
group
sensit
day
lycopen
mgkg
bw
glycyrrhizin
mgkg
bw
given
oral
day
day
mice
normal
control
model
group
given
salin
oral
day
day
day
experi
overnight
fast
six
rat
group
anesthet
sodium
pentobarbit
mgkg
bodi
weight
weigh
blood
collect
abdomin
aorta
tube
contain
edta
plasma
prepar
lowspe
centrifug
g
min
nasal
mucosa
remov
immedi
rins
cold
salin
weigh
store
use
tissu
immedi
homogen
cold
mm
trishcl
ph
wv
upanddown
stroke
approxim
revmin
teflonglass
homogen
homogen
centrifug
g
min
yield
clear
supernat
fraction
use
biochem
analysi
ovaspecif
ige
titrat
plate
coat
ova
biotinconjug
rat
mab
mous
ige
clone
use
detect
antibodi
level
ovaspecif
antibodi
compar
ige
standard
predetermin
concentr
ige
concentr
standard
serum
arbitrarili
assign
elisa
unit
eu
malonaldehyd
mda
concentr
determin
use
method
describ
jain
et
al
base
tba
reactiv
gsh
concentr
measur
use
method
describ
beutler
et
al
catalas
cat
activ
determin
accord
aebi
method
rate
h
decomposit
follow
monitor
absorpt
nm
one
unit
cat
activ
defin
amount
enzym
requir
decompos
hydrogen
peroxid
min
enzym
activ
express
h
consumedminmg
protein
superoxid
dismutas
sod
activ
estim
accord
method
beauchamp
fridovich
develop
blue
color
reaction
measur
nm
unit
sod
activ
express
amount
enzym
requir
inhibit
reduct
nbt
activ
express
umg
protein
activ
glutathion
peroxidas
gshpx
determin
accord
method
lawrenc
burk
assay
mixtur
consist
ml
mm
phosphat
buffer
ph
mm
glutathion
ml
unitsml
glutathion
reductas
ml
mm
edta
ml
mm
nadph
appropri
amount
tissu
supernat
final
volum
ml
reaction
start
addit
ml
mm
h
rate
chang
absorb
convers
nadph
nadp
record
spectrophotometr
nm
min
gshpx
activ
tissu
express
nadph
oxid
nadp
min
mg
protein
antioxid
activ
taoc
serum
tissu
homogen
determin
enzymat
method
use
correspond
diagnost
kit
nanj
jiancheng
bioengin
institut
nanj
china
accord
instruct
manufactur
level
measur
immunoassay
level
measur
use
elisa
kit
diaclon
research
franc
data
obtain
express
mean
sd
n
signific
differ
mean
taa
determin
examin
oneway
anova
use
gener
linear
model
procedur
statist
analysi
system
statist
softwar
packag
version
sa
institut
cari
nc
usa
differ
p
consid
statist
signific
untreat
ar
mice
sneez
thin
nasal
discharg
accompani
excess
scratch
glycyrrhizintr
group
mgkg
bw
abnorm
symptom
found
howev
ar
mice
treat
glycyrrhizin
mgkg
bw
sneez
thin
nasal
discharg
accompani
slightli
scratch
lycopenetr
group
sneez
thin
nasal
discharg
accompani
slightli
scratch
experi
seriou
purul
nasal
discharg
none
experiment
anim
develop
secondari
infect
treat
addit
drug
antibiot
medicinetr
group
two
mice
die
seen
tabl
bodi
weight
significantli
higher
p
untreat
ar
mice
normal
control
mice
p
mice
receiv
oral
administr
lycopen
glycyrrhizin
lower
bodi
weight
untreat
ar
mice
howev
statist
differ
found
addit
mice
receiv
oral
administr
lycopen
mg
kg
bw
slightli
p
lower
bodi
weight
mice
receiv
equival
dose
glycyrrhizin
seen
tabl
ova
specif
ige
level
significantli
higher
p
untreat
ar
mice
normal
control
mice
p
oral
administr
glycyrrhizin
significantli
dosedepend
manner
p
p
reduc
ova
specif
ige
level
untreat
ar
mice
compar
normal
control
mice
oral
administr
lycopen
slightli
p
reduc
ova
specif
ige
level
untreat
ar
mice
compar
normal
control
seen
tabl
blood
nasal
mucosa
mda
content
significantli
higher
untreat
ar
mice
normal
control
mice
p
decreas
significantli
p
p
medicinetr
lycopen
glycyrrhizin
group
compar
untreat
ar
mice
p
mice
receiv
oral
administr
lycopen
mg
kg
bw
markedli
p
lower
concentr
mda
mice
receiv
equival
dose
glycyrrhizin
tabl
show
blood
nasal
mucosa
gsh
level
end
experi
day
treatment
gsh
concentr
untreat
ar
mice
show
signific
p
decreas
compar
normal
control
mice
howev
increas
gsh
concentr
mice
medicinetr
lycopen
glycyrrhizin
group
observ
p
dosedepend
relationship
gsh
concentr
glycyrrhizin
consumpt
mice
receiv
oral
administr
lycopen
mg
kg
bw
higher
concentr
gsh
mice
receiv
equival
dose
glycyrrhizin
sod
cat
gshpx
taoc
activ
significantli
p
decreas
blood
nasal
mucosa
untreat
ar
mice
compar
normal
control
mice
decreas
significantli
restor
p
mice
supplement
lycopen
glycyrrhizin
tabl
dosedepend
relationship
antioxid
enzym
activ
glycyrrhizin
consumpt
mice
receiv
oral
administr
lycopen
mg
kg
bw
higher
antioxid
enzym
activ
mice
receiv
equival
dose
glycyrrhizin
tabl
show
nasal
mucosa
level
end
experi
day
treatment
concentr
untreat
ar
mice
show
signific
p
decreas
increas
compar
normal
control
mice
subsequ
markedli
decreas
howev
lycopen
glycyrrhizin
administr
significantli
p
increas
nasal
mucosa
reduc
concentr
mice
medicinetr
lycopen
glycyrrhizin
group
subsequ
markedli
increas
dosedepend
relationship
level
glycyrrhizin
consumpt
mice
receiv
oral
administr
lycopen
mg
kg
bw
lower
higher
level
mice
receiv
equival
dose
glycyrrhizin
oxid
stress
play
import
role
allerg
disord
increas
level
oxid
consid
marker
inflammatori
process
overproduct
oxygen
free
radic
natur
scaveng
mechan
weaken
process
implic
cell
damag
multiorgan
failur
present
studi
found
significantli
lower
plasma
nasal
mucosa
total
antioxid
statu
untreat
ar
mice
observ
support
earlier
report
glycyrrhizin
use
natur
sweeten
antiulc
antiinflammatori
prepar
glycyrrhizin
report
exhibit
antivir
antihiv
antitumor
antioxid
immunomodulatori
activ
synthesi
glycyrrhizin
analogu
proven
commerci
feasibl
studi
conduct
earlier
glycyrrhizin
shown
counteract
ccl
induc
hepatotox
antioxid
potenti
major
compon
licoric
root
glycyrrhizin
consist
glycyrrhet
acid
two
molecul
glucuron
acid
shown
glycyrrhizin
biolog
transform
metabolit
call
acid
aglycon
compon
glycyrrhizin
inhibit
passiv
cutan
anaphylaxi
skin
contact
inflamm
mice
model
contact
hypersensit
lycopen
red
pigment
tomato
known
potent
antioxid
dietari
intak
tomato
tomato
product
reportedli
associ
decreas
risk
cardiovascular
diseas
sever
type
cancer
especi
prostat
cancer
treatment
anim
glycyrrhizin
significantli
amelior
gsh
content
concomit
decreas
mda
suggest
glycyrrhizin
establish
antioxid
properti
might
counteract
oxid
injuri
ar
mice
effect
scaveng
block
conjug
reactiv
intermedi
gsh
evid
amelior
gsh
content
decreas
mda
format
dose
depend
manner
concomit
decreas
observ
gpx
cat
taoc
sod
activ
ar
mice
treatment
glycyrrhizin
lycopen
led
signific
increas
mention
enzym
result
indic
use
glycyrrhizin
therapi
ar
allow
oxid
stress
abolish
reduc
correct
antioxid
system
evid
result
glycyrrhizin
induc
varieti
enzym
phase
ii
enzym
involv
detoxif
excret
carcinogen
toxic
substanc
antioxid
enzym
respons
maintain
balanc
state
free
radicalsoxid
antioxid
within
cellular
environ
addit
blood
level
markedli
reduc
level
increas
ar
mice
treatment
glycyrrhizin
led
signific
increas
level
decreas
level
medicinetr
mice
type
ii
interferon
cytokin
critic
innat
adapt
immun
viral
intracellular
bacteri
infect
tumor
control
aberr
express
associ
number
autoinflammatori
autoimmun
diseas
abbrevi
cytokin
induc
differenti
naiv
helper
cell
cell
cell
upon
activ
cell
subsequ
produc
addit
mani
biolog
role
includ
stimul
activ
bcell
tcell
prolifer
differenti
tcell
cell
treatment
glycyrrhizin
may
induc
cell
differenti
matur
product
addit
reduc
lge
synthesi
possibl
inhibit
cell
differenti
matur
product
subsequ
prevent
ar
develop
likewis
lycopen
increas
level
decreas
level
medicinetr
mice
lee
et
al
report
lycopen
reduc
increas
level
ovachalleng
mice
agreement
result
lycopen
reduc
increas
level
mrna
ovachalleng
mice
suggest
lycopen
treatment
novel
select
way
simultan
suppress
increas
tbet
express
asthmat
reaction
vivo
human
bodi
glycyrrhizin
hydrolys
glycyrrhetin
acid
triterpenoid
structur
similar
hormon
adren
cortex
recent
research
shown
glycyrrhetin
acid
inhibit
enzym
steroid
dehydrogenas
respons
convert
cortisolth
activ
forminto
inact
metabolit
thu
inhibit
enzym
glycyrrhetin
acid
significantli
increas
level
cortisol
also
stimul
glucocorticoid
receptor
turn
potenti
action
hydrocortison
main
glucocorticoid
secret
adren
cortex
hydrocortison
associ
account
glyrrhizin
glycyrrhetin
acid
antiinflammatori
antiallerg
antiarthrit
effect
also
role
stimul
adren
cortex
steroid
therapi
fangzhibiyan
tablet
produc
guangxi
yunl
pharmaceut
co
ltd
effect
allevi
patient
suffer
ar
glycyrrhizin
import
function
compon
tablet
short
treatment
glycyrrhizin
may
consid
therapeut
option
ar
patient
exampl
increas
antioxid
capac
counteract
oxid
injuri
andor
improv
control
inadequ
inflammatori
immun
respons
far
know
first
work
show
antioxid
immun
effect
glycyrrhizin
ar
mice
conclus
ar
mice
glycyrrhizin
consumpt
decreas
blood
nasal
mucosa
antioxid
enzym
activ
lipid
peroxid
gsh
level
enhanc
reduc
level
thu
protect
nasal
mucosa
oxid
injuri
improv
immun
activ
ar
mice
inhibit
effect
glycyrrhizin
nasal
mucosa
oxid
injuri
increas
increas
concentr
studi
requir
determin
caus
behind
distinct
effect
glycyrrhizin
